5,820 results on '"Katus, Hugo A."'
Search Results
152. Basophils balance healing after myocardial infarction via IL-4/IL-13
153. Beta blockers and chronic heart failure patients: prognostic impact of a dose targeted beta blocker therapy vs. heart rate targeted strategy
154. Use of the wearable cardioverter-defibrillator (WCD) and WCD-based remote rhythm monitoring in a real-life patient cohort
155. Cardiovascular pharmacology of K2P17.1 (TASK-4, TALK-2) two-pore-domain K+ channels
156. NOAC monotherapy in patients with concomitant indications for oral anticoagulation undergoing transcatheter aortic valve implantation
157. Role of ion channels in heart failure and channelopathies
158. Guía ESC 2020 para el tratamiento de las cardiopatías congénitas del adulto
159. Successful localization and ablation of a Mahaim potential using a high-resolution mapping catheter after a failed conventional ablation attempt
160. Cardio-oncology: conflicting priorities of anticancer treatment and cardiovascular outcome
161. Genomic structural variations lead to dysregulation of important coding and non‐coding RNA species in dilated cardiomyopathy
162. Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals
163. CXCL4-induced PBMCs Modulate Vascular Extracellular Matrix through Wnt5a-dependent Release of Calcific Extracellular Vesicles and Matrix Metalloproteinase-7
164. Cardiological parameters predict mortality and cardiotoxicity in oncological patients
165. The management of atrial fibrillation with oral anticoagulant drugs—an analysis of guideline adherence in the setting of the ARENA project
166. Abstract 686: Glp-2 Predicts Cardiovascular Outcomes In Patients With Myocardial Infarction And Increases Atherosclerosis In Mice
167. Mid-regional pro-adrenomedullin and lactate levels for risk stratification in patients with out-of-hospital cardiac arrest
168. Cardiac-targeted rAAV5-S100A1 gene therapy protects against adverse remodeling and contractile dysfunction in post-ischemic hearts
169. S100A1ct: a synthetic peptide derived from human S100A1 protein improves cardiac contractile performance and survival in pre-clinical heart failure models
170. Biomarker Concentrations and Their Temporal Changes in Patients With Myocardial Infarction and Nonobstructive Compared With Obstructive Coronary Arteries : Results From the PLATO Trial
171. Modification of the GRACE Risk Score for Risk Prediction in Patients With Acute Coronary Syndromes
172. AMP-activated protein kinase α1-sensitive activation of AP-1 in cardiomyocytes
173. Galectin-3 binding protein plasma levels are associated with long-term mortality in coronary artery disease independent of plaque morphology
174. Diagnostic and prognostic implications using age- and gender-specific cut-offs for high-sensitivity cardiac troponin T — Sub-analysis from the TRAPID-AMI study
175. Prognostic Value of Undetectable hs Troponin T in Suspected Acute Coronary Syndrome
176. Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexia
177. Fibroblast growth factor 23 (FGF-23) is an early predictor of mortality in patients with cardiac arrest
178. Critical role of RAGE and HMGB1 in inflammatory heart disease
179. Robust Image-Based Estimation of Cardiac Tissue Parameters and Their Uncertainty from Noisy Data
180. Genetic Ablation of TASK-1 (Tandem of P Domains in a Weak Inward Rectifying K+ Channel–Related Acid-Sensitive K+ Channel-1) (K2P3.1) K+ Channels Suppresses Atrial Fibrillation and Prevents Electrical Remodeling
181. O-GlcNAcylation of Histone Deacetylase 4 Protects the Diabetic Heart From Failure
182. Monitoring Cell-Type–Specific Gene Expression Using Ribosome Profiling In Vivo During Cardiac Hemodynamic Stress
183. Value of adenosine stress cardiovascular magnetic resonance in the evaluation of vessels supplying previously infarcted territories
184. Protein Misfolding in Cardiac Disease
185. Genetics of cardiomyopathies: dilated cardiomyopathy
186. Outcomes Associated With Cardiogenic Shock in Takotsubo Syndrome: Results From the International Takotsubo Registry
187. ATF6 Regulates Cardiac Hypertrophy by Transcriptional Induction of the mTORC1 Activator, Rheb
188. Biomarkers in acute coronary syndromes
189. PRAS40 suppresses atherogenesis through inhibition of mTORC1-dependent pro-inflammatory signaling in endothelial cells
190. Atrial Fibrillation
191. TIP30 counteracts cardiac hypertrophy and failure by inhibiting translational elongation
192. Prognostic value of novel imaging parameters derived from standard cardiovascular magnetic resonance in high risk patients with systemic light chain amyloidosis
193. Augmentation of myocardial If dysregulates calcium homeostasis and causes adverse cardiac remodeling
194. ST-segment elevation myocardial infarction
195. Pathophysiological background and prognostic implication of systolic aortic root motion in non-ischemic dilated cardiomyopathy
196. Effects of MitraClip on cognitive and psychological function in heart failure patients: the sicker the better
197. Safety of Stress Cardiac Magnetic Resonance in Patients With Moderate to Severe Aortic Valve Stenosis
198. Addition of copeptin improves diagnostic performance of point-of-care testing (POCT) for cardiac troponin T in early rule-out of myocardial infarction — A pilot study
199. Patients at Intermediate Surgical Risk Undergoing Isolated Interventional or Surgical Aortic Valve Implantation for Severe Symptomatic Aortic Valve Stenosis: One-Year Results From the German Aortic Valve Registry
200. Long-term effect of a low-intensity smoking intervention embedded in an adherence program for patients with hypercholesterolemia: Randomized controlled trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.